ACM Global Laboratories   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Rochester NY United States (1997)

Organization Overview

First Clinical Trial
2008
NCT00668850
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ACM | ACM Global Europe | ACM Global Laboratories | ACM Laboratories | ACM Pivotal Global Central Laboratory